• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prolonged hypogammaglobulinemia following rituximab treatment for post transplant Epstein-Barr virus-associated lymphoproliferative disease.

作者信息

Imashuku S, Teramura T, Morimoto A, Naya M, Kuroda H

出版信息

Bone Marrow Transplant. 2004 Jan;33(1):129-30. doi: 10.1038/sj.bmt.1704307.

DOI:10.1038/sj.bmt.1704307
PMID:14647260
Abstract
摘要

相似文献

1
Prolonged hypogammaglobulinemia following rituximab treatment for post transplant Epstein-Barr virus-associated lymphoproliferative disease.利妥昔单抗治疗移植后爱泼斯坦-巴尔病毒相关淋巴增殖性疾病后出现的持续性低丙种球蛋白血症。
Bone Marrow Transplant. 2004 Jan;33(1):129-30. doi: 10.1038/sj.bmt.1704307.
2
Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy.利妥昔单抗用于预防爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病治疗后出现的持久性低丙种球蛋白血症。
J Hematother Stem Cell Res. 2003 Feb;12(1):9-10. doi: 10.1089/152581603321210082.
3
Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.自体骨髓移植后爱泼斯坦-巴尔病毒相关淋巴增殖性疾病：两例报告
Bone Marrow Transplant. 1998 Jun;21(12):1271-4. doi: 10.1038/sj.bmt.1701258.
4
Epstein-Barr virus-associated, CD20- polyclonal lymphoproliferative disorder after matched unrelated donor marrow transplantation.匹配无关供者骨髓移植后与爱泼斯坦-巴尔病毒相关的CD20阴性多克隆淋巴细胞增殖性疾病
Bone Marrow Transplant. 2004 Nov;34(10):919-21. doi: 10.1038/sj.bmt.1704683.
5
Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients.爱泼斯坦-巴尔病毒亚型、人类白细胞抗原I类等位基因与骨髓移植受者移植后淋巴细胞增殖性疾病发生之间的关联。
Clin Infect Dis. 2007 Mar 1;44(5):693-5. doi: 10.1086/511647. Epub 2007 Jan 24.
6
Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.接受利妥昔单抗治疗的心脏移植患者中，爱泼斯坦-巴尔病毒聚合酶链反应阴性的IV期移植后淋巴增殖性疾病
J Heart Lung Transplant. 2008 Aug;27(8):928-31. doi: 10.1016/j.healun.2008.05.020. Epub 2008 Jul 3.
7
Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation.骨髓移植后爱泼斯坦-巴尔病毒（EBV）相关多克隆淋巴细胞增殖性疾病（LPD）的持续时间。
Bone Marrow Transplant. 1996 Oct;18(4):823-4.
8
[Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].[器官移植中与爱泼斯坦-巴尔病毒相关的淋巴增殖综合征]
Med Clin (Barc). 1996 Sep 14;107(8):310-6.
9
Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.造血干细胞移植后监测爱泼斯坦-巴尔病毒载量以早期干预移植后淋巴细胞增生性疾病。
J Med Virol. 2008 Mar;80(3):441-54. doi: 10.1002/jmv.21096.
10
Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantation.肝移植后用于治疗移植后淋巴增殖性疾病的利妥昔单抗治疗相关的肠穿孔。
Cancer Chemother Pharmacol. 2009 Sep;64(4):857-60. doi: 10.1007/s00280-009-1062-1. Epub 2009 Jul 9.

引用本文的文献

1
Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect.接受 HSCT 后持续性低丙种球蛋白血症并非由固有 B 细胞缺陷引起。
Int J Mol Sci. 2023 Nov 6;24(21):16012. doi: 10.3390/ijms242116012.
2
Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab.利妥昔单抗治疗后低丙种球蛋白血症、迟发性中性粒细胞减少和感染。
Ann Allergy Asthma Immunol. 2023 Jun;130(6):699-712. doi: 10.1016/j.anai.2023.01.018. Epub 2023 Jan 24.
3
Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT.
病例报告：异基因造血干细胞移植后给予利妥昔单抗 10 多年后持续低丙种球蛋白血症
Front Immunol. 2021 Dec 22;12:773853. doi: 10.3389/fimmu.2021.773853. eCollection 2021.
4
Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults?利妥昔单抗治疗儿童和青少年后的免疫重建和感染并发症：我们从成人那里了解到什么，又可以学到什么？
Cancers (Basel). 2015 Jan 29;7(1):305-28. doi: 10.3390/cancers7010305.
5
Immunoglobulin replacement therapy in secondary hypogammaglobulinemia.继发性低丙种球蛋白血症的免疫球蛋白替代治疗。
Front Immunol. 2014 Dec 8;5:626. doi: 10.3389/fimmu.2014.00626. eCollection 2014.
6
Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.皮下注射免疫球蛋白治疗淋巴增殖性疾病及利妥昔单抗相关的继发性低丙种球蛋白血症：61例患者的单中心经验
Haematologica. 2014 Jun;99(6):1101-6. doi: 10.3324/haematol.2013.101261. Epub 2014 Mar 28.
7
Central nervous system involvement of epstein barr virus associated lymphoproliferative disorder in a child with acute lymphoblastic leukemia: successful treatment with rituximab and interferon-alpha.儿童急性淋巴细胞白血病中 EBV 相关淋巴组织增生性疾病累及中枢神经系统：利妥昔单抗和干扰素-α治疗成功。
Turk J Haematol. 2013 Mar;30(1):58-62. doi: 10.4274/tjh.2011.0047. Epub 2013 Mar 5.
8
Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens.实体器官移植受者移植后淋巴增殖性疾病的管理：免疫抑制剂方案的综述。
Drugs. 2012 Aug 20;72(12):1631-43. doi: 10.2165/11635690-000000000-00000.
9
B cell depletion for autoimmune diseases in paediatric patients.B 细胞耗竭治疗儿科自身免疫性疾病。
Clin Rheumatol. 2011 Jan;30(1):87-97. doi: 10.1007/s10067-010-1630-0. Epub 2010 Dec 1.
10
Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis.由于 B 淋巴细胞分化停滞以及 T 淋巴细胞稳态改变，在用利妥昔单抗联合化疗治疗后 6 年内持续存在严重低丙种球蛋白血症。
Int J Hematol. 2010 Apr;91(3):501-8. doi: 10.1007/s12185-010-0528-6. Epub 2010 Mar 10.